Veru Inc. Made Headway

Veru Inc. (VERU:NASDAQ) jumped higher at $14.1, a gain of 25.8%. The stock got featured on our News Catalysts scanner on Mon, Apr 25, 2022 at 11:02 AM in the 'BIOTECH' category. From Fri, Apr 08, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Thu, Apr 14, 2022 at $17.5 with a volume of 179M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Nkarta Inc. (NKTX:NASDAQ), 140.93%
- ION Geophysical Corporation (IO:NYSE), 46.29%
- Cango Inc. (CANG:NYSE), 40.68%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 40.6%
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 37.7%
- Redbox Entertainment Inc. (RDBX:NASDAQ), 37.54%
- Ardelyx, Inc. (ARDX:NASDAQ), 31.77%
- GWG Holdings, Inc. (GWGH:NASDAQ), 31.14%
- ImmuCell Corporation (ICCC:NASDAQ), 29.04%
- Veru Inc. (VERU:NASDAQ), 25.78%